JPRN-jRCT2080222603未知1 期
Phase I study of TMS-007 in healthy adult male
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 45age old(—)
- 性别
- Male
入选标准
- •Healthy male volunteers
排除标准
- •1) Serious medical history
- •2) High risk of bleeding
- •3) Drug-dependence
- •4) Allergy to medical drug or constituents of the test drug formulation
- •5) Major surgery within past 3 months
研究者
相似试验
未知
1 期
Phase 1 Clinical Study of TS-071 in Healthy Male Adults (Repeated Administration)Healthy Japanese male subjectsJPRN-jRCT2080222305Taisho Pharmaceutical co., LTD24
未知
1 期
Phase 1 Clinical Study of TS-071 in Healthy Adult Male Subjects (Single-Dose Administration)Healthy Japanese male subjectsJPRN-jRCT2080222304Taisho Pharmaceutical co., LTD57
已完成
2 期
A single-dose study of TMS-007 in patients with ischemic stroke (phase IIa study)Acute ischemic strokeJPRN-jRCT2080223786TMS Co., Ltd.90
已完成
1 期
A phase I study of TS-172 in healthy adult subjects (Single and Multiple doses)Healthy adult subjectsJPRN-jRCT2071210043Mita Seiji41
已完成
1 期
Phase1 Study of TS-141 in Healthy Volunteers-JPRN-jRCT2080225139Taisho Pharmaceutical Co.Ltd48
